Schroder Investment Management Group
GNCA

Schroder Investment Management Group’s Genocea Biosciences, Inc. GNCA Stock Holding History

Schroder Investment Management Group’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-438
Closed -$45K – 1246
2015
Q2 		$45K Hold
438
– – ﹤0.01% 1122
2015
Q1 		$41K Hold
438
– – ﹤0.01% 1155
2014
Q4 		$25K Hold
438
– – ﹤0.01% 1237
2014
Q3 		$31.7K Hold
438
– – ﹤0.01% 1310
2014
Q2 		$65.6K Hold
438
– – ﹤0.01% 1221
2014
Q1 		$63.7K Buy
+438
New +$53.7K ﹤0.01% 1262

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Schroder Investment Management Group's GNCA Position: Q3 2015 in Review

Schroder Investment Management Group sold out of Genocea Biosciences, Inc. (GNCA) in Q3 2015, closing a stake of 438 shares — an estimated $45K sold.

Schroder Investment Management Group first reported a position in GNCA in Q1 2014 and held it in 6 quarters. The position peaked at $65.6K in Q2 2014. 70 funds tracked by Wall St. Rank hold GNCA as of Q3 2015.

  • Schroder Investment Management Group reported no remaining Genocea Biosciences, Inc. position as of Q3 2015 after selling out during the quarter.
  • Schroder Investment Management Group sold 438 Genocea Biosciences, Inc. shares in Q3 2015, an estimated $45K.
  • Schroder Investment Management Group first reported a position in Genocea Biosciences, Inc. in Q1 2014 and held it in 6 quarters.
  • Schroder Investment Management Group's Genocea Biosciences, Inc. position peaked at $65.6K in Q2 2014.
  • 70 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2015.

Based on Schroder Investment Management Group's 13F filing for Q3 2015, filed 13 Nov 2015.